Paper

Efficacy and tolerability of a generic and a branded formulation of atorvastatin 20 mg/d in hypercholesterolemic Korean adults at high risk for cardiovascular disease: a multicenter, prospective, randomized, double-blind, double-dummy clinical trial.

Published Oct 1, 2010 · Sang-Hyun Kim, K. Park, Soon-Joon Hong

Clinical therapeutics

Citations

Influential Citations

Abstract

Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Study Snapshot

Key takeawayBoth generic and branded formulations of atorvastatin 20 mg/d effectively lower LDL-C levels in hypercholesterolemic Korean adults at high risk for cardiovascular events, with both being generally well-tolerated.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Efficacy and tolerability of a generic and a branded formulation of atorvastatin 20 mg/d in hypercholesterolemic Korean adults at high risk for cardiovascular disease: a multicenter, prospective, randomized, double-blind, double-dummy clinical trial.

References

Citations